Cargando…

Determinants of HIV-1 Late Presentation in Patients Followed in Europe

To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm(3) or an AIDS-defini...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Mafalda N. S., Pingarilho, Marta, Pimentel, Victor, Martins, Maria do Rosário O., Vandamme, Anne-Mieke, Bobkova, Marina, Böhm, Michael, Seguin-Devaux, Carole, Paredes, Roger, Rubio, Rafael, Zazzi, Maurizio, Incardona, Francesca, Abecasis, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308660/
https://www.ncbi.nlm.nih.gov/pubmed/34357985
http://dx.doi.org/10.3390/pathogens10070835
_version_ 1783728334075592704
author Miranda, Mafalda N. S.
Pingarilho, Marta
Pimentel, Victor
Martins, Maria do Rosário O.
Vandamme, Anne-Mieke
Bobkova, Marina
Böhm, Michael
Seguin-Devaux, Carole
Paredes, Roger
Rubio, Rafael
Zazzi, Maurizio
Incardona, Francesca
Abecasis, Ana
author_facet Miranda, Mafalda N. S.
Pingarilho, Marta
Pimentel, Victor
Martins, Maria do Rosário O.
Vandamme, Anne-Mieke
Bobkova, Marina
Böhm, Michael
Seguin-Devaux, Carole
Paredes, Roger
Rubio, Rafael
Zazzi, Maurizio
Incardona, Francesca
Abecasis, Ana
author_sort Miranda, Mafalda N. S.
collection PubMed
description To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm(3) or an AIDS-defining event. The present study aims to identify determinants of late presentation in Europe based on the EuResist database with HIV-1 infected patients followed-up between 1981 and 2019. Our study includes clinical and socio-demographic information from 89851 HIV-1 infected patients. Statistical analysis was performed using RStudio and SPSS and a Bayesian network was constructed with the WEKA software to analyze the association between all variables. Among 89,851 HIV-1 infected patients included in the analysis, the median age was 33 (IQR: 27.0–41.0) years and 74.4% were males. Of those, 28,889 patients (50.4%) were late presenters. Older patients (>56), heterosexuals, patients originated from Africa and patients presenting with log VL >4.1 had a higher probability of being late presenters (p < 0.001). Bayesian networks indicated VL, mode of transmission, age and recentness of infection as variables that were directly associated with LP. This study highlights the major determinants associated with late presentation in Europe. This study helps to direct prevention measures for this population.
format Online
Article
Text
id pubmed-8308660
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83086602021-07-25 Determinants of HIV-1 Late Presentation in Patients Followed in Europe Miranda, Mafalda N. S. Pingarilho, Marta Pimentel, Victor Martins, Maria do Rosário O. Vandamme, Anne-Mieke Bobkova, Marina Böhm, Michael Seguin-Devaux, Carole Paredes, Roger Rubio, Rafael Zazzi, Maurizio Incardona, Francesca Abecasis, Ana Pathogens Article To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm(3) or an AIDS-defining event. The present study aims to identify determinants of late presentation in Europe based on the EuResist database with HIV-1 infected patients followed-up between 1981 and 2019. Our study includes clinical and socio-demographic information from 89851 HIV-1 infected patients. Statistical analysis was performed using RStudio and SPSS and a Bayesian network was constructed with the WEKA software to analyze the association between all variables. Among 89,851 HIV-1 infected patients included in the analysis, the median age was 33 (IQR: 27.0–41.0) years and 74.4% were males. Of those, 28,889 patients (50.4%) were late presenters. Older patients (>56), heterosexuals, patients originated from Africa and patients presenting with log VL >4.1 had a higher probability of being late presenters (p < 0.001). Bayesian networks indicated VL, mode of transmission, age and recentness of infection as variables that were directly associated with LP. This study highlights the major determinants associated with late presentation in Europe. This study helps to direct prevention measures for this population. MDPI 2021-07-02 /pmc/articles/PMC8308660/ /pubmed/34357985 http://dx.doi.org/10.3390/pathogens10070835 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Miranda, Mafalda N. S.
Pingarilho, Marta
Pimentel, Victor
Martins, Maria do Rosário O.
Vandamme, Anne-Mieke
Bobkova, Marina
Böhm, Michael
Seguin-Devaux, Carole
Paredes, Roger
Rubio, Rafael
Zazzi, Maurizio
Incardona, Francesca
Abecasis, Ana
Determinants of HIV-1 Late Presentation in Patients Followed in Europe
title Determinants of HIV-1 Late Presentation in Patients Followed in Europe
title_full Determinants of HIV-1 Late Presentation in Patients Followed in Europe
title_fullStr Determinants of HIV-1 Late Presentation in Patients Followed in Europe
title_full_unstemmed Determinants of HIV-1 Late Presentation in Patients Followed in Europe
title_short Determinants of HIV-1 Late Presentation in Patients Followed in Europe
title_sort determinants of hiv-1 late presentation in patients followed in europe
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308660/
https://www.ncbi.nlm.nih.gov/pubmed/34357985
http://dx.doi.org/10.3390/pathogens10070835
work_keys_str_mv AT mirandamafaldans determinantsofhiv1latepresentationinpatientsfollowedineurope
AT pingarilhomarta determinantsofhiv1latepresentationinpatientsfollowedineurope
AT pimentelvictor determinantsofhiv1latepresentationinpatientsfollowedineurope
AT martinsmariadorosarioo determinantsofhiv1latepresentationinpatientsfollowedineurope
AT vandammeannemieke determinantsofhiv1latepresentationinpatientsfollowedineurope
AT bobkovamarina determinantsofhiv1latepresentationinpatientsfollowedineurope
AT bohmmichael determinantsofhiv1latepresentationinpatientsfollowedineurope
AT seguindevauxcarole determinantsofhiv1latepresentationinpatientsfollowedineurope
AT paredesroger determinantsofhiv1latepresentationinpatientsfollowedineurope
AT rubiorafael determinantsofhiv1latepresentationinpatientsfollowedineurope
AT zazzimaurizio determinantsofhiv1latepresentationinpatientsfollowedineurope
AT incardonafrancesca determinantsofhiv1latepresentationinpatientsfollowedineurope
AT abecasisana determinantsofhiv1latepresentationinpatientsfollowedineurope